[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367632-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367632-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cxcl8-is-essential-for-cervical-cancer-cell-acquired-radioresistance-and-acts-as-a-promising-therapeutic-target-in-cervical-cancer","CXCL8 is essential for cervical cancer cell acquired radioresistance and acts as a promising therapeutic target in cervical cancer","","Acquired radioresistance severely undermines cervical cancer radiotherapy, and clinically relevant radioresistant models are limited, leaving the function of CXCL8 in this context insufficiently defined. Two radioresistant cervical cancer cell strains were generated using irradiation protocols mirroring clinical practice. mRNA-seq and bioinformatics highlighted CXCL8 as a key mediator among radiosensitivity regulators. Functional assays showed CXCL8 knockdown sensitized resistant cells to radiation, whereas exogenous CXCL8 conferred resistance, with tumor overexpression supported by GEPIA2 and immunohistochemistry.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cxcl8-is-essential-for-cervical-cancer-cell-acquired-radioresistance-and-acts-as-a-promising-therapeutic-target-in-cervical-cancer/367632/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cxcl8-is-essential-for-cervical-cancer-cell-acquired-radioresistance-and-acts-as-a-promising-therapeutic-target-in-cervical-cancer/367632.png","ImageObject",300,407,{"name":42,"@type":43},"Đào","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is acquired radioresistance a major problem in cervical cancer radiotherapy?","Question",{"text":63,"@type":64},"Acquired radioresistance critically challenges treatment effectiveness, contributing to tumor growth, recurrence, and distant metastasis, which leads to outcomes that often fall short of expectations.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the radioresistant cervical cancer cell models established?",{"text":68,"@type":64},"Two radioresistant cervical cancer cell strains were generated through clinical protocol-mimicking irradiation, validated using proliferation, clonogenic, and cell-cycle assays.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does CXCL8 play according to the study’s functional experiments?",{"text":72,"@type":64},"CXCL8 knockdown sensitized radioresistant cells to radiation, while adding exogenous CXCL8 induced radioresistance in parental cervical cancer cell lines.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367632,1790198108,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374402968488,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nCXCL8 is essential for cervical cancer cell acquired radioresistance and acts as a promising therapeutic target in cervical cancer  \nQinghong Hu1, Xiaoxiao Zuo1, Xiaobin Gu1, Liya Liu2, Ying Tang2, Xiaomin Niu2, Yonggang Shi1 & Liping Han2􀀍  \nAcquired radioresistance critically challenges cervical cancer radiotherapy management. Clinically relevant radioresistant cell models remain scarce, and CXCL8’s role in cervical cancer—despite its tumorigenic/therapy-resistant associations in other cancers—is poorly characterized. Two radioresistant cervical cancer cell strains were established. mRNA-seq and bioinformatics analysis of radiosensitivity regulators identified CXCL8 as a key mediator. In vitro, assays of cell viability, clone formation, apoptosis and cell cycle were conducted following transient transfection of cervical cancer radiotherapy-resistant cell strains with knockdown of CXCL8, as well as subsequent addition of exogenous CXCL8 to cervical cancer parental cell strains. Radioresistant cervical cancer cell lines (Hela-RR/Siha-RR) were established through clinical protocol-mimicking irradiation, validated via proliferation/clonogenic/cell cycle assays. mRNA-seq identified 50 co-upregulated and 54 codownregulated genes in resistant strains, with CXCL8 among top differentially expressed genes (IL11, CXCL8, MMP1, HSPA8, CA9, PPFIA4, EDN2, GUCY1A2, EFNA3, TNFAIP6). qRT-PCR confirmed CXCL8, TNFAIP6, SRNA8 and PPFIA4 dysregulation. Cox regression analysis of 96 candidate radiosensitivity regulators prioritized CXCL8 among eight key genes in cervical cancer. GEPIA2 and immunohistochemistry revealed CXCL8 overexpression in tumors. Functional studies demonstrated CXCL8 knockdown sensitized resistant cells to radiation, while exogenous CXCL8 induced resistance in parental lines.  \nKeywords Cervical cancer, Radioresistance, CXCL8, Radiosensitization, Tumor microenvironment  \nAbbreviations  \nAUC Area under the ROC curve  \nCC Cervical cancer  \nCRRF Cancer radiosensitivity regulation factor  \nCSC Cancer stem cell  \nCXCL8 C-X-C motif chemokine ligand 8 CXCR C-X-C motif chemokine receptor DDR DNA damage response  \nEMT Epithelial–mesenchymal transition GEPIA Gene expression profiling interactive analysis HIF Hypoxic inducible factor  \nHR Homologous recombination  \nICI Immune checkpointInhibitors LACC Locally advanced cervical cancer NHEJ Nonhomologous end-joining PDX Patient-derived xenograft  \nRR Radiotherapy resistance  \nRT Radiotherapy  \n1Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China. 2Department of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China. 􀀍 email: [Hhanliping0825@163.com](Hhanliping0825@163.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nTAM Tumor-associated macrophages TAN Tumor-associated neutrophil  \nTCGA The Cancer Genome Atlas  \nTME Tumor microenvironment  \nCervical cancer (CC), the most prevalent gynecological malignancy, remains a major global health issue, contributing significantly to disability-adjusted life years1. In 2020, an estimated 604,127 new cases and 341,831 deaths from CC were reported worldwide, making it the fourth most common cancer among women2. While incidence rates have decreased in Europe and the United States, they remain high in Hispanic, Latino, and Asian populations3. Prevention relies heavily on screening and immunization, with 88.5% of cases occurring in lowincome countries, where CC remains the leading cause of cancer-related deaths among women4. Due to its often asymptomatic nature and poor healthcare access, over two-thirds of patients present with locally advanced or metastatic disease at diagnosis. The standard treatment for locally advanced CC (LACC) involves cisplatin-based concurrent chemoradiotherapy, with a 5-year survival rate ranging from 20 to 65%, a result wi","cbCaimS9dhLsmgVZ","https://ap.wps.com/l/cbCaimS9dhLsmgVZ","pdf",7261266,18,"English","# Background\n## Radiotherapy resistance in cervical cancer\n## Tumor microenvironment and resistance mechanisms\n# CXCL8 in radioresistance\n## Establishment of radioresistant cell models\n## Transcriptomic identification of CXCL8\n# Experimental validation\n## Gene expression confirmation\n## Functional effects on radiosensitivity\n# Clinical relevance\n## Tumor overexpression analysis\n## Therapeutic targeting rationale","[{\"question\":\"Why is acquired radioresistance a major problem in cervical cancer radiotherapy?\",\"answer\":\"Acquired radioresistance critically challenges treatment effectiveness, contributing to tumor growth, recurrence, and distant metastasis, which leads to outcomes that often fall short of expectations.\"},{\"question\":\"How were the radioresistant cervical cancer cell models established?\",\"answer\":\"Two radioresistant cervical cancer cell strains were generated through clinical protocol-mimicking irradiation, validated using proliferation, clonogenic, and cell-cycle assays.\"},{\"question\":\"What role does CXCL8 play according to the study’s functional experiments?\",\"answer\":\"CXCL8 knockdown sensitized radioresistant cells to radiation, while adding exogenous CXCL8 induced radioresistance in parental cervical cancer cell lines.\"}]","CXCL8 is essential for cervical cancer cell acquired radioresistance and acts as a promising therapeutic target in cervical cancer | PDF",1790171713,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c6768dbc27b443f126514310d8bec14.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d9704ac8959179dad0340abc18b321e.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10294ca9387c0756528d2f58105130c9.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f698aaa2ba1efc8bba79d7874f32e089.webp",980,1287]